InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,718.00
(
0.20%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.84
(
0.55%
)
Bitcoin
62,743.73
(
2.11%
)
Post# of 2109
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

pmony5

Send PM Follow Ignore
Followers 27
Posts 1204
Boards Moderated 0
Alias Born 09/11/2010

pmony5

Re: bioresearcher post# 705

Monday, 07/15/2013 2:22:05 PM

Monday, July 15, 2013 2:22:05 PM

Post# of 2109
Agreed APPY has always maintained trial & results by years end ... not sure where new earlier dates came from perhaps some of the new shorts lol... GLTA & make $$$$$$$$$$$

CEO stating in interview....

The study will enroll 2,000 evaluable patients in total and we expect to complete enrollment and report top-line data by the end of the year. We plan to submit our 510(k) package to the FDA as soon as possible

http://seekingalpha.com/article/1522902-exclusive-interview-with-stephen-lundy-venaxis-president-and-ceo?source=yahoo
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up